ALTx Therapeutics launched to develop novel cancer treatments
Slingshot Therapeutics has launched ALTx Therapeutics with funding worth £12.55 million ($17.04 million) to develop novel treatments for cancer. ALTx Therapeutics launched into the Slingshot accelerator with backing from Syncona, the Francis Crick Institute and Cancer Research Horizons. Spinning out of the Crick, ALTx is focused on developing therapeutics targeting vulnerabilities… Read More
